Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03334708 · ClinicalTrials.gov registry record
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
A clinical trial of Pancreatic Cancer and Pancreatic Cyst, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 700
- Enrollment target
- 13
- Study locations
NCT03334708: Recruiting study of Pancreatic Cancer and Pancreatic Cyst, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03334708 is a study of Pancreatic Cancer and Pancreatic Cyst that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 700 participants, above the 391-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (79% higher). The trial reports 13 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03334708, a study of Pancreatic Cancer and Pancreatic Cyst, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood Draw
- DIAGNOSTIC_TEST Tumor Tissue Collection
- DIAGNOSTIC_TEST Cyst Fluid
Study Locations (13)
New York
- Cold Springs Harbor Laboratory (Specimen Analysis) - Cold Spring Harbor
- Memorial Sloan Kettering Cancer Center @ Commack (All Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (All protocol activities) - Harrison
- New York University - New York
- Memorial Sloan - Kettering Cancer Center - New York
- Memorial Sloan Kettering Basking Ridge (All protocol activities) - New York
- Weill Cornell Medical Center - New York
- Memorial Sloan Kettering Nassau (All protocol activities) - Rockville Centre
Other
- Sha'are Zedek Medical Center - Jerusalem
- Weizmann Institute of Science - Rehovot
- Sheba Medical Center - Tel Litwinsky
New Jersey
- Memorial Sloan Kettering Monmouth (All protocol activities) - Middletown
- Memorial Sloan Kettering Bergen (All protocol activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2017-10-30 |
| Est. Completion | 2026-10-30 |
What NCT03334708 shows while recruiting
NCT03334708 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, above the 391-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (79% higher).
The record links to 4 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 3 interventions - of which Blood Draw is the first listed.
NCT03334708 lists 13 locations in 3 states (New York, Other, New Jersey).
Frequently Asked Questions
What is clinical trial NCT03334708 about?
NCT03334708 is a clinical study titled "A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma". The purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment.
What is the current status of trial NCT03334708?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2017-10-30. Estimated completion is 2026-10-30.
What conditions does trial NCT03334708 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Pancreatic Cyst, Pancreatitis, Pancreatic Diseases.
What interventions are being tested in trial NCT03334708?
The interventions under investigation include: Blood Draw (DIAGNOSTIC_TEST), Tumor Tissue Collection (DIAGNOSTIC_TEST), Cyst Fluid (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03334708?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03334708 being conducted?
This trial has 13 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03334708's enrollment target sits among peer trials
700 21st of 278 higher than 258 of 278 other Pancreatic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
RECRUITING · Phase 1
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI